Rabies: epidemiology,diagnosis,prevention,and prospects for worldwide control

Centers for Disease Control and Prevention Human rabies-California, 1987. MMWR 1988; 37, 305–308.

Smith J.S. Fishbein D.B. Rupprecht C.E. Clark C. Unexplained rabies in three immigrants in the United States: a virologic investigation. NEngl JMed 1991; 324, 205–211.

Smith J.S. Seidel H.D. Rabies: a new look at an old disease. Prog Med Virol 1993; 40, 82–106.

Meara F.S. The Treatment of Acute Infectious Diseases 2nd ed London: Macmillan, 1921, 699 revised, cited by Grattan-Smith et al. [59].

Sureau P. History of rabies: advances in research towards rabies prevention during the last 30 years. Rev Infect Dis 1988; 10(supp 4), S581–S584.

Fekadu M Canine rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 367–378.

Steele J.H. Fernandez P.J. History of rabies and global aspects. In: Baer G.M. ed. The Natural History o f Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 1–24.

Blancou J. Aubert M.F.A. Artois M. Fox rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 257–290.

Baer G.M. Vampire bat and bovine paralytic rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 389–403.

Augusto L.R. Percy M.P. Edgar T.V. Fishbein D.B. Outbreak of human rabies in the Peruvian jungle. Lancet 1992; 1, 408–411.

Debbie J.G. Rabies control of terrestrial wildlife by population reduction. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 477–485.

Joshi D.D. Bögel K. Role of lesser developed nations in rabies research. Rev Infect Dis 1988; 10(supp. 4), S600–S603.

Bögel K. Motschwiller E. Incidence of rabies and post-exposure treatment in developing countries. Bull WH0 1986; 64, 883–887.

Sehgal S. Bhatia R. eds. Rabies: current status in India Proceedings of Workshop on Rabies Surveillance and Control. National Institute of Communicable Diseases, October 15-17, 1985. Delhi: National Institute of Communicable Diseases (Directorate General of Health Service), 1985: 10–18 cited by Baer and Fishbein [18].

Fishbein D.B. Rabies in humans. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 519–549.

Lakhanpal U. Sharma R.C. An epidemiological study of 177 cases of human rabies. Int J Epidemiol 1985; 14, 614–617.

Nicholson K.G. Modern vaccines: rabies. Lancet 1900; 1, 1201–1205.

Baer G.M. Fishbein D.B. Rabies post-exposure prophylaxis (Editorial). N Engl J Med 1987; 316, 1270–1272.

Hattwick M.A.W. Weis T.T. Stechschulte C.J. Baer G.M. Gregg M.B. Recovery from rabies; a case report. Ann Intern Med 1972; 76, 931–942.

Porras C. Barboza J.J. Fuenzalida E. Adaris Gk. De Díaz A.M.O. Furst J. Recovery from rabies in man. Ann Intern Med 1976; 85, 44–48.

Centers for Disease Control and Prevention Rabies in a laboratory worker. MMWR 1977; 26, 183–184.

Centers for Disease Control and Prevention Human rabies - Texas, Arkansas, and Georgia, 1991. MMWR 1991; 44, 765–769.

Anderson L.J. Nicholson K.G. Tauxe R.V. Winkler W.V. Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention. Ann Intern Med 1984; 100, 728–735.

Pacer R.E. Fishbein D.B. Baer G.M. Jenkins S.R. Smith J.S. Rabies in the United States and Canada, 1983. MMWR 1985; 34, 11SS–27SS.

Centers for Disease Control and Prevention Human rabies - Texas, 1990. MMWR 1991; 40, 132–133.

Centers for Disease Control and Prevention Human rabies - California, 1992. MMWR 1992; 41, 461–463.

Centers for Disease Control and Prevention Compendium of animal rabies control, 1988. Prepared by The National Association of State Public Health Veterinarians, Inc.. MMWR 1992; 41(No. RR-7), 1–8.

Reid-Sanden F.L. Dobbins J.G. Smith J.S. Fishbein D.B. Rabies surveillance in the United States during 1989. JAm Vet Med Assoc 1990; 197, 1571–1583.

Bunn T.O. Cat rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 379–387.

Baer G.M. Oral rabies vaccination: an overview. Rev Infect Dis 1988; 10(supp. 4), S644–S648.

MacInnes C.D. Tinline R.R. Voigt D.R. Broekhoven L.H. Rosatte R.R. Planning for rabies control in Ontario. Rev Infect Dis 1988; 10(supp. 4), S665–S669.

Smith J.S. Rabies virus epitopic variation: Use in ecologic studies. Adv Virus Res 1989; 36, 215–253.

Centers for Disease Control and Prevention Extension of the raccoon rabies epizootic - United States, 1992. MMWR 1992; 41, 661–664.

Chomel B.B. The modern epidemiological aspects of rabies in the world. Comp Immun Microbiol Infect Dis 1993; 16, 11–20.

Jenkins S.R. Perry B.D. Winkler W.G. Ecology and epidemiology of raccoon rabies. Rev Infect Dis 1988; 10(supp 4), S620–S625.

Winkler W.G. Jenkins S.R. Raccoon rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 325–340.

Charlton K.M. Webster W.A. Casey G.A. Rupprecht C.E. Skunk rabies. Rev Infect Dis 1988; 10(supp. 4), S626–S628.

Smith J.S. Monoclonal antibody studies of rabies in insectivorous bats of the United States. Rev Infect Dis 1988; 10, S637–S643 supp 4.

Blancou J. Ecology and epidemiology of fox rabies. Rev Infect Dis 1988; 10(supp 4), S606–S609.

Dietzschold B. Rupprecht C.E. Tollis M. Lafon M. Mattei J. Wiktor T.J. Koprowski H. Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Rev Infect Dis 1988; 10(supp. 4), S785–S798.

Hill R.E. Beran G.W. Experimental inoculation of raccoons (Procyon lotor) with rabies virus of skunk origin. J Wildlife Dis 1992; 28, 51–56.

Hill R.E. Smith K.E. Beran G.W. Beard P.D. Further studies on the susceptibility of raccoons (Procyon lotor) to a rabies virus of skunk origin and comparative susceptibility of striped skunks (Mephitis mephitis). J Wildlife Dis 1993; 29, 475–477.

Beran G.W. Urban rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 427–444.

Baer G.M. Smith J.S. Rabies in nonhematophagous bats. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 341–366.

World Health Organization WHO Expert Committee on Rabies. Geneva: World Health Organization, 1992: Eighth Report. (WHO Technical Report Series, No. 824).

Rosatte R.C. Bat rabies in Canada: history, epidemiology and prevention. Can Vet J 1987; 28, 754–756.

Tuttle M.D. Kern S.J. Bats and public health28,1981Milwaukee Public Museum: Contributions in Biology and Geology No. 48.

Rupprecht C.E. Dietzschold B. Wunner W.H. Koprowski H. Antigenic relationships of Lyssaviruses. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 69–100.

Centers for Disease Control and Prevention Human rabies - Oregon, 1989. MMWR 1989; 38, 335–336.

McKendrick A.G. A ninth analytical review of reports from Pasteur Institutes on the results of antirabies treatment. Bull RHO 1940; 9, 30 cited by Fishbein [15].

Centers for Disease Control and Prevention Rabies surveillance 1986. MMWR 1987; 36(No. 3S).

Constantine D.G. Rabies transmission by nonbite route. Public Health Reports 1992; 77, 287–289.

Constantine D.G. Rabies Transmission byAir in Bat Caves. Atlanta, GA: US Dept. HEW, CDC, 1967.

Bek M.D. Smith W.T. Levy M.H. Sullivan E. Rubin G.L. Rabies case in New South Wales, 1990: public health aspects. Med JAust 1992; 156, 596–600.

Winkler W.G. Fashinell T.R. Lefhngwell L. Howard P. Conomy J.P. Airborne rabies transmission in a laboratory worker. JAMA 1973; 226, 1219–1221.

Centers for Disease Control and Prevention Rabies prevention - United States, 1991: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 1991; 40(No. RR-3).

Winkler W.G. Rodent rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 405–410.

Crandell R.A. Arctic fox rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 291–306.

Grattan-Smith P.J. O'regan W.J. Ellis P.S. O'flaherty S.J. Mcintyre P.B. Barnes C.J. Rabies: a second Australian case, with a long incubation period. Med J Aust 1992; 156, 651–654.

Centers for Disease Control and Prevention Imported human rabies - Australia, 1987. MMWR 1988; 37, 351–353.

Arai Y.T. Ogata T. Oya A. Studies on Japanese-produced chick embryo cell culture rabies vaccines. Am J Trop Med Hyg 1991; 44, 131–134.

Steele J.H. Rabies in the Americas and remarks on global aspects. Rev Infect Dis 1988; 10(supp 4), S585–S597.

Tyrell D.A.J. Nicholson K.G. Rabies in Britain. B Med J 1990; 300, 137–138.

Bögel K. Meslin F.-X. Economics of human and canine rabies elimination: guidelines for programme orientation. Bull WHO 1990; 68, 281–291.

Wilde H. Chutivongse S. Tepsumethanon W. Choomkasien P. Polsuwan C. Lumbertdacha B. Rabies in Thailand: 1990. Rev Infect Dis 1991; 13, 644–652.

Fekadu M. Rabies in Ethiopia. Am JEpidemiol 1982; 115, 266–273.

Held J.R. Escalante J.A. Winkler W.G. The international management of rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 505–512.

Wandeler A.I. Budde A. Capt S. Kappeler A. Matter H. Dog ecology and dog rabies control. Rev Infect Dis 1988; 10(supp 4), S684–S688.

Flores-Crespo R. Arellano-Sota C. Biology and control of the vampire bat. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 461–476.

Warrell D.A. Warrell M.J. Human rabies and its prevention: an overview. Rev Infect Dis 1988; 10(supp 4), S726–S731.

Arellano-Sota C. Biology, ecology, and control of the vampire bat. Rev Infect Dis 1988; 10(supp 4), S615–S619.

Arellano-Sota C. Vampire bat-transmitted rabies in cattle. Rev Infect Dis 1988; 10(supp 4), S707–S709.

Centers for Disease Control and Prevention Bat rabies-Europe. MMWR 1986; 35, 430–432.

Lumio J. Hillbom M. Roine R. Ketonen L. Haltia M. Valle M. Neuvonen E. Lahdevirta J. Human rabies of bat origin in Europe (Letter to the Editor). Lancet 1986; 1, 378.

Linhart S.B. Creekmore T.E. Corn J.L. Whitney M.B. Snyder B.D. Nettles V.F. Evaluation of baits for oral rabies vaccination of mongooses: pilot field trials in Antigua, West Indies. J Wildlife Dis 1993; 29, 290–294.

Everard C.O.R. Everard J.D. Mongoose rabies. Rev Infect Dis 1988; 10(supp 4), S610–S614.

Shlim D.R. Schwartz E. Houston R. Rabies immunoprophylaxis strategy in travelers. J Wilderness Med 1991; 2, 15–21.

Houff S.A. Burton R.C. Wilson R.W. Henson T.E. London W.T. Baer G.M. Anderson L.J. Winkler W.G. Madden D.L. Sever J.L. Human-to-human transmission of rabies virus by corneal transplant. NEnglJMed 1979; 300, 603–604.

Centers for Disease Control and Prevention Human-to-human transmission of rabies via corneal transplant - Thailand. MMWR 1981; 30, 473–474.

Joshi D.D. Regmi D.N. Relation between site of bite, type of bite, type of animal bite, and incubation period of hydrophobia cases. J Inst Med (Nepal) 1983; 5, 135–136 cited by Shlim et al. [77].

Baer G.M. Lentz T.L. Rabies pathogenesis to the central nervous system. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 105–120.

Fekadu M. Pathogenesis of rabies virus infection in dogs. Rev Infect Dis 1988; 10(supp 4), S678–S683.

Charlton K.M. Webster W.A. Casey G.A. Skunk rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 307–324.

Rupprecht C.E. Dietzschold B. Editorial: perspectives on rabies virus pathogenesis. Lab Invest 1987; 57, 603–606.

Baer G.M. Overview to Part II: pathogenesis and pathology. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 103–104.

Divestea A. Zagari G. Sulla transmissione rabbia per la via dei nervi. Ann Neurol 1887; 5, 113 cited by Baer and Lentz [81].

Divestea A. Zagari G. La transmission de la rage par voie nerveuse. Pasteur Ann 1889; 3, 237 cited by Baer and Lentz [81].

Iwasaki Y. Spread of virus within the central nervous system. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 121–132.

Schneider L.G. Spread of virus from the central nervous system. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 133–144.

Koprowski H. Glimpses into the future of rabies research. Rev Infect Dis 1988; 10(supp 4), S810–S813.

Bartarelli E. Ueber die Wege, auf denen das Wutvirus zu den Speicheldrusen des Hundes gelangt. Centrabl Bakt 1908; 37, 213 cited by Baer and Lentz [81].

Nathanson N. Gonzalez-Scarano F. Immune response to rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 145–161.

Perl D.P. Good P.F. The pathology of rabies in the central nervous system. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 163–190.

Babes V. Sur certains caracteres des histologiques de la rage. Ann InstPasteurParis 1892; 6, 209 cited by Perl and Good [93].

Van Gehuchten A. Nelis C. Les lesions histologiques de la rage chez les animaux et chez l'homme. Bull Acad R Med Belg 1900; 14, 31 cited by Perl and Good [93].

Van Gehuchten A. Les lesions histologiques dans la rage humane. Sem Med 1900; 20, 40 cited by Perl and Good [93].

Negri A. Beitrag zum studium der aetiologie der Tollwut. Zentralbl Bakteriol Parasitenkd InfektionskrHyg 1903; 43, 507–528 cited by Bourhy et al. [111].

Bosc F.J. Etude et signification des lesions de la rage, lesions du systeme nerveaus. CR Soc Biol 1903; 55, 1284 cited by Perl and Good [93].

Bosc F.J. Recherches sur 1'etiologie de la rage. CR Soc Biol 1903; 55, 1436 cited by Perl and Good [93].

Sureau P. Ravisse P. Rollin P.E. Rabies diagnosis by animal inoculation, identification of Negri bodies, or ELISA. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 203–217.

Gribencha S.V. Gribanova L.Y. Malkov G.B. Barinsky Population structure of some street rabies virus strains. Arch Virol 1989; 104, 347–350.

Ogunkoya A.B. Beran G.W. Umoh J.U. Bomwalk N.E. Abdulkadir I.A. Serologic evidence of infection of dogs and man in Nigeria by Lyssaviruses (family Rhabdoviridae). Trans Roy Soc Trop Med Hyg 1990; 84, 842–845.

Rupprecht C.E. Hamir AX Johnston D.H. and Koprowski H. Efficacy of a vaccinia-rabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Rev Infect Dis 1988; 10(supp 4), S803–S809.

Fekadu M. Latency and aborted rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 191–198.

Pasteur L. Chamberland C.E. Roux M. Nouveaux faits pour servir a la connaissance de la rage. CRAcad Sci 1882; 95, 1187 cited by Steele [7].

Fekadu M. Baer G.M. Recovery from clinical rabies of 2 dogs inoculated with a rabies virus strain from Ethiopia. Am J Vet Res 1980; 41, 1632–1634.

Baer G.M. Olson H.R. Recovery of pigs from rabies. J Am Vet Med Assoc 1972; 160, 1127–1132.

Remington P.L. Shope T. Andrews J. A recommended approach to the evaluation of human rabies exposure in an acute-care hospital. JAMA 1985; 254, 67–69.

Trimarchi C.V. Debbie J.G. The fluorescent antibody in rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 219–233.

Goldwasser R.A. Kissling R. Fluorescent antibody staining of street and fixed rabies virus antigens. Proc Soc Exp Biol Med 1958; 98, 219–223.

Bourhy H. Rollin P.E. Vincent J. Sureau P. Comparative field evaluation of the fluorescent-antibody test, viral isolation from tissue culture, and enzyme immunodiagnosis for rapid laboratory diagnosis of rabies. J Clin Microbiol 1989; 27, 519–523.

Rudd R.T. Trimarchi C.V. Development and evaluation of an in vitro virus isolation procedure as a replacement for the mouse inoculation test in rabies diagnosis. J Clin Microbiol 1989; 27, 2522–2528.

Vodopija I. Overview to Part VI: rabies and its prevention in man. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 515–517.

Rubin R.J. Corey L. Preventing rabies in humans. South Med J 1974; 67, 472–475.

Parham G.L. Rabies in the United States, 1981. MMWR 1983; 32, 33SS–37SS.

Sitthi-Amorn C. Jiratanavattana V. Keoyoo J. Sonpunya N. The diagnostic properties of laboratory tests for rabies. Intern J Epidemiol 1987; 16, 602–605.

Fekadu M. Shaddock J.H. Baer G.M. Intermittent excretion of rabies virus in the saliva of a dog two and six months after it had recovered from experimental rabies. Am J Trop Med Hyg 1981; 30, 1113–1115.

Centers for Disease Control Imported human rabies. MMWR 1983; 32, 78–80 85-86.

Vodopija I. Sureau P. Smerdel S. Lafon M. Baklaic Z. Ljubicic M. Svjetlicic M. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for post-exposure treatment. Vaccine 1988; 6, 283.

Fangtao L. The protective effect of the large-scale use of PHKC rabies vaccine in humans in China. Bull WHO 1990; 68, 449–454.

Cabasso V.J. Local Wound Treatment and Passive Immunization. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 551–570.

Babes V. Lepp. Recherches sur la vaccination antirabique. Ann Inst Pasteur 1889; 2, 385 cited by Cabasso [121].

Baltazard M. Bahmanyar M. Essai pratique du serum antirabique chez les mordus par loups enrages. Bull WHO 1955; 13, 747–772 cited by Bahmanyar et al. [126].

Fangtao L. Shubeng C. Yinzhon W. Chenzhe S. Fanzhen Z. Guanfu W. Use of serum and vaccine in combination for prophylaxis following exposure to rabies. Rev Infect Dis 1988; 10(supp 4), S766–S770.

Devriendt J. Staroukine M. Costy F. Vanderhaeghen J-J. Fatal encephalitis apparently due to rabies: occurrence after treatment with human diploid cell vaccine but not rabies immune globulin. JAMA 1982; 248, 2304–2306.

Bahmanyar M. Fayaz A. Nour-Salehi S. Mohammadi M. Koprowski H. Successful protection of humans exposed to rabies infection: postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum. JAMA 1976; 236, 2751–2754.

Wilde H. Chutivongse S. Equine rabies immune globulin: A product with an undeserved poor reputation. Am J Trop Med Hyg 1990; 42, 175–178.

Wilde H. Chomchey P. Punyaratabandhu P. Phanupak P. Chutivongse S. Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin. Bull WHO 1989; 67, 731–736.

Schumacher C.L. Dietzschold B. Ertl H.J.C. Niu H-S. Rupprecht C.E. Koprowski H. Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies. J Clin Invest 1989; 84, 971–975.

Wallace C.K. Opening remarks (International Symposium on Research Towards Rabies Prevention). Rev Infect Dis 1988; 10(supp 4), S579–S581.

Vodopija I. Clark H.F. Human vaccination against rabies. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 571–595.

Babes V. TraW de la rage , Paris: Bailliere et Fils, 1921, 81–119 cited by Baer [30].

Swamy H.S. Shankar S.K. Chandra P.S. Aroor S.R. Krishna A.S. Perumal V.G.K. Neurological complications due to beta-propiolactone (BPL) -inactivated antirabies vaccination. J Neurol Sci 1984; 63, 111–128.

Roux E. Not sur un moyen de conserver les moelles rabiques avec leur virulence. Ann Inst Pasteur (Paris) 1987; 1, 87 cited by Vodopija and Clark [131].

Calmette A. Notes sur la rage en lndochine et sur les vaccinations antirabiques practiques a Saigon du 14 avril au ler aout. Ann InstPasteur (Paris) 1891; 5, 633 cited by Vodopija and Clark [131].

Hemachudha T. Griffin D.E. Johnson R.T. et al. Immunologic studies of patients with chronic encephalitis induced by post-exposure Semple rabies vaccine. Neurology 1988; 38, 42–44.

Fuenzalida E. Palacios R. Rabies vaccine prepared from brains of infected suckling mice. Boletin Inst Bacteriol Chile 1955; 8, 3–10 cited by Sureau [5].

Wang S.P. Statistical studies of human rabies in Taiwan. J Formosa Med Assoc 1956; 55, 548 cited by Vodopija and Clark [131].

Baltazard M. Ghodssi M. Prevention de la rage humaine. Rev Immunol 1953; 17, 366 cited by Bahmanyar et al. [126].

Vibulbandhitkij S. Work Report. Data From The Rabies Patients At Bamrasnaradura Hospital Between 1971 and 1977. In: Thongcharoen P. ed. Rabies , Bangkok: Aksarasamai, 1980, 235–251 cited by Warrell et al. [160].

Veeraraghavan N. Subrahmanyan T.P. The value of 5 per cent Semple vaccine prepared in distilled water in human treatment: comparative mortality among the treated and untreated. Ind JMed Res 1958; 46, 518–524 cited by Nicholson [17].

Baer G.M. Animal Models. The Pathogenesis and Treatment Of Rabies.; Rev Infect Dis 1988; 10(supp 4), S739–S750.

Gremliza L. Kasusistik zum Lyssa-Problem. Z Tropenmed Parasitol 1953(4)382–389 cited by Bahmanyar et al. [126].

Hemachudha T. Phanuphak P. Johnson R.T. Griffin D.E. Ratanavongsiri J. Siriprasomsup W. Neurologic complications of Semple-type rabies vaccine: clinical and immunologic studies. Neurology 1987; 37, 550–556.

Bareggi C. Su cinque casi di rabia paralitica (de laboratorio) nell'uomo. Gass Med Lombarda 1889; 48, 217–279 cited by Swamy [133].

Remlinger P. Accidents paralytiques au cours du tratement antirabique. Ann Inst Pasteur Paris 1905; 19, 625 cited by Steele [7].

Bunn T.O. Canine and Feline Vaccines, Past and Present. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 415–425.

Swaddiwuthipong W. Weniger B.G. Wattanasri S. Warrell M.J. A high rate of neurological complications following Semple anti-rabies vaccine. Trans Roy Soc Trop Med Hyg 1988; 82, 472–475.

Hemachudha T. Griffin D.E. Giffels J.J. Johnson R.T. Moser A.B. Phanuphak P. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 1987; 316, 369–374.

Javier R.S. Kunishita T. Koike F. Tabira T. Semple rabies vaccine: presence of myelin basic protein and proteolipid protein and its activity in experimental allergic encephalomyelitis. J Neurol Sci 1989; 93, 221–230.

Chaleomchan W. Hemachudha T. Sakulramrung R. Deesomchok U. Anticardiolipin antibodies in patients with rabies vaccination induced neurological complications and other neurological diseases. JNeurol Sci 1990; 96, 143–151.

Rubin R.H. Hattwick M.A.W. Jones S. Gregg M.B. Schwartz V.D. Adverse reactions to duck embryo rabies vaccine: Range and incidence. Ann Intern Med 1973; 78, 643–649.

Centers For Disease Control and Prevention Systemic allergic reactions following immunization with human diploid cell rabies vaccine. MMWR 1984; 33, 185–187.

Morrison A.J. Hunt E.H. Atuk N.O. Schwartzman J.D. Wenzel R.P. Rabies preexposure prophylaxis using intradermal human diploid cell vaccine: immunologic efficacy and cost-effectiveness in a university medical center and a review of selected literature. Am J Med Sci 1987; 293, 293–297.

Immunization Unit Calif. Health and Welfare Agency Immunization Update 1993, Berkeley, CA: Dept. Health Services, 10–11.

Shill M. Baynes R.D. Miller S.D. Fatal rabies encephalitis despite appropriate postexposure prophylaxis. N Engl J Med 1987; 316, 1257–1258.

Centers For Disease Control and Prevention Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine - Thailand. MMWR 1987; 36, 759–765.

Roumiantzeff M. Ajjan N. Vincent-Falquet J.C. Experience with preexposure rabies vaccination. Rev Infect Dis 1988; 10(supp 4), S751–S757.

Bernard K.W. Smith P.W. Kader F.J. Moran M.J. Neuroparalytic illness and human diploid cell rabies vaccine. JAMA 1982; 248, 3136–3138.

Warrell M.J. Nicholson K.G. Warrell D.A. Suntharasamai P. Chanthavanich P. Viravan C. Sinhaseni A. Chiewbamproongkiat M.K. Pouradier-Duteil X. Xueref C. Phanfung R. Udomsakdi D. Economical multiple-site intradermal immunization with human diploidcell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985; 1, 1059–1062.

Phanuphak P. et al. Humoral and Cell-Mediated Immune Responses To Various Economical Regimens Of Purified Vero-Cell Rabies Vaccine. Asian Pacific JAller Immunol 1987; 5, 33–37 cited by Phanuphak et al. [162].

Phanuphak P. Khaoplod P. Benjavongkulchai M. Chutivongse S. Wilde H. What happens if intradermal injections of rabies vaccine are partially or entirely injected subcutaneously?. Bull WHO 1990; 68, 83–85.

Chutivongse S. Wilde H. Supich C. Baer G.M. Fishbein D.B. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990; 1, 896–898.

Berlin B.S. Rabies vaccine adsorbed: Neutralizing antibody titers after three-dose preexposure vaccination. Am J Pub Health 1990; 80, 476–477.

Halstead S.B. Tissue culture-based rabies vaccines: vaccine production technology transfer. Rev Infect Dis 1988; 10(supp 4), S764–S765.

Wandeler A.I. Oral immunization of wildlife. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 485–503.

Johnston D.H. Voight D.R. Macinnes C.D. Bachmann P. Lawson K.F. Rupprecht C.E. An aerial baiting system for the distribution of attenuated or recombinant rabies vaccines for foxes, raccoons, and skunks. Rev Infect Dis 1988; 10(supp 4), S660–S663.

Robbins F.C. Closing remarks. Rev Infect Dis 1988; 10(supp 4), S814–S815.

Belloto A.J. Organization of mass vaccination for dog rabies in Brazil. Rev Infect Dis 1988; 10(supp 4), S693–S696.

Rosatte R.C. Pybus M.J. Gunson J.R. Population reduction as a factor in the control of skunk rabies in Alberta. J Wildlife Dis 1986; 22, 459–467.

Brochier B. Kieny M.P. Costy F. Coppens P. Bauduin B. Lecocq J.P. Languet B. Chappuis G. Desmettre P. Afiademanyo K. Libois R. Pastoret P-P. Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine. Nature 1991; 354, 520–522.

Wilhelm U. Schneider L.G. Oral immunization of foxes against rabies: Practical experiences of a field trial in the Federal Republic of Germany. Bull WHO 1990; 68, 87–92.

Linhart S.B. Some factors affecting the oral rabies vaccination of free-ranging carnivores. Rev Sci Tech Off IntEpiz 1993; 12, 109–113.

Rosatte R.C. Power M.J. Macinnes C.D. Campbell J.B. Trap-vaccinate-release and oral vaccination for rabies control in urban skunks, raccoons and foxes. J Wildlife Dis 1992; 28, 562–571.

Rosatte R.C. Macinnes C.D. Power M.J. Johnston D.H. Bachmann P. Nunan C.P. Wannop C. Peddie M. Calder J. Tactics for the control of wildlife rabies in Ontario (Canada). Rev Sci Tech Off Int Epiz 1992; 12, 95–98.

Wunner W.H. Larson J.K. Dietzschold B. Smith C.L. The molecular biology of rabies viruses. Rev Infect Dis 1988; 10(supp 4), S771–S784.

Préhaud C. Coulon P. Diallo A. Martinet-Edelist C. Flamand A. Characterization of new temperature-sensitive and avirulent mutant of the rabies virus. J Gen Virol 1989; 70, 133–143.

Wunner W.H. The Chemical Composition and Molecular Structure Of Rabies Viruses. In: Baer G.M. ed. The Natural History of Rabies . 2nd ed Boca Raton, FL: CRC Press, 1991, 31–67.

Celis E. Miller R.W. Wiktor T.J. Dietzschold B. Koprowski H. Isolation and characterization of human T cell lines and clones reactive to rabies virus: antigen specificity and production of interferon-T. J Immunol 1986; 136, 692–697.

Préhaud C. Takehara K. Flamand A. Bishop D.H.L. Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors. Virology 1989; 173, 390–399.

Dietzschold B. Wunner W.H. Wiktor T.J. Lopez A.D. Lafon M. Smith C.L. Koprowski H. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc NatlAcad Sci, USA 1983; 80, 70–74.

Fu Z.F. Dietzschold B. Schumacher C.L. Wunner W.H. Ertl H.C.J. Koprowski H. Rabies virus nucleoprotein expressed in and purified from insect cells is efficacious as a vaccine. Proc Natl Acad Sci USA 1992; 88, 2001–2005.

Sumner J.W. Fekadu M. Shaddock J.H. Esposito J.J. Bellini W.J. Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein. Virology 1991; 183, 703–710.

Cadoz M. Strady A. Meignier B. Taylor J. Tartaglia J. Paoletti E. Plotkin S. Immunization with canarypox virus expressing rabies glycoprotein. Lancet 1992; 1, 1429–1432.

Préhaud C. Harris R.D. Fulop V. Koh C-L. Wong J. Flamand A. Bishop D.H.L. Expression, characterization, and purification of a phosphorylated rabies nucleoprotein synthesized in insect cells by baculovirus vectors. Virology 1990; 176, 486–497.

Reid-Sanden F.L. Sumner J.W. Smith J.S. Fekadu M. Shaddock J.H. Bellini W.J. Rabies diagnostic reagents prepared from a rabies N gene recombinant expressed in baculovirus. J Clin Microbiol 1990; 28, 858–863.

Fu Z.F. Rupprecht C.E. Dietzschold B. Saikuman P. Niu H.S. Babke I. Wunner W.H. Koprowski H. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein. Vaccine 1993; 11, 925–928.

Prevec L. Campbell J.B. Christie B.S. Belbeck L. Graham F.L. A recombinant human adenovirus vaccine against rabies. J Infect Dis 1990; 161, 27–30.

Charlton K.M. Artois M. Prevec L. Campbell J.B. Casey G.A. Wandeler A.I. Armstrong J. Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine. Arch Virol 1992; 123, 169–179.

Centers For Disease Control and Prevention.; Human Rabies-Michigan. MMWR 1983; 32, 159–161.

Centers For Disease Control and Prevention.; Human Rabies-Pennsylvania. MMWR 1984; 33, 633–635.

Centers For Disease Control and Prevention Human rabies acquired outside the United States. MMWR 1985; 34, 235–236.

Centers For Disease Control and Prevention Human Rabies-New York. MMWR 1993; 42, 805–806 799.

Centers For Disease Control and Prevention Human Rabies-Texas and California. MMWR 1994; 43, 93–96.